Speaker Details

R.T. (Terry) Hisey
Vice Chairman & US Life Sciences Leader, Deloitte LLP

R.T. (Terry) Hisey is the vice chairman and U.S. Life Sciences Leader for Deloitte LLP. Terry leads efforts for the Life Sciences sector in the fields of tax, audit, consulting and financial advisory services to assist clients in achieving sustainable competitive advantage through strategic change.

His life sciences experience spans the entire value chain including drug discovery & development, commercial operations, production & distribution, and regulatory compliance. His responsibilities include linking the life sciences effort with those in Health Providers, Health Plans, and Government to identify and capitalize on the unique capabilities that Deloitte offers based on our depth in all aspects of the value chain. Terry is chairman of the Life Sciences Advisory Board for Deloitte Research and is a Steering Committee member for the Deloitte Center for Health Solutions in Washington, D.C. Terry is also on the committee of the Deloitte Health Sciences & Government Eminence Collaboration Board, which seeks to coordinate thought leadership development and commercialization across our functions, sectors, Deloitte Research and the Center for Health Solutions.

Terry is a key leader in Deloitte's Life Sciences Health Reform advisory services, helping our clients address some of their most challenging issues compounded by the requirements of Health Reform. Terry personally heads up the Comparative Effectiveness and Informatics solution, tackling the increasing issues of information access and use of real world data to inform product safety and life cycle decisions. Terry also advises clients on other transformative opportunities in the industry including social media and globalization.

Terry was previously the vice president and national leader of the life sciences practice of a major global consulting & integration firm and was a global leader in their efforts regarding life sciences thought leadership in strategy, transformation and operations. Terry has personal client experience with a number of pharmaceutical and biotechnology firms and offers extensive expertise in corporate strategy, M&A, value chain management, product development, marketing and customer relationship management.

In addition to his client work, Terry is a noted industry authority, a frequent speaker, a strategy advisor to Pharmaceutical Executive Magazine, and a guest lecturer at several schools including the University of Pennsylvania, Drexel University and the University of California at Berkeley. Terry is also a member of several industry associations and advisory boards.

 

Back